Anabaseine

Anabaseine
Names
Other names
3,4,5,6-Tetrahydro-2,3'-bipyridin
Identifiers
3471-05-4 YesY
ChEBI CHEBI:80787 YesY
ChemSpider 17923 YesY
347
Jmol interactive 3D Image
KEGG C06522 YesY
PubChem 18985
Properties
C10H12N2
Molar mass 160.22 g·mol−1
Appearance Oil
Odor Odorless
Boiling point 110-120℃
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
YesY verify (what is YesYN ?)
Infobox references

Anabaseine (3,4,5,6-Tetrahydro-2,3’-bipyridine) is an alkaloid toxin produced by Nemertines and Aphaenogaster ants.[1] It is structurally similar to nicotine and anabasine.[2] Similarly, it has been shown to act as an agonist on most nicotinic acetylcholine receptors in the central nervous system and peripheral nervous system.[2]

Mechanism of action

The iminium form of anabaseine binds to most nicotinic acetylcholine receptors in both the peripheral nervous system and central nervous system. But, there is a higher binding affinity for receptors in the brain with a α7 subunit, as well as skeletal muscle receptors.[3] Binding causes the depolarization of neurons, and induces the release of release of both dopamine and norepinephrine.[2]

Biological effects

Anabaseine causes paralysis in crustaceans and insects, but not in vertebrates, presumably by acting as an agonist on peripheral neuromuscular nicotinic acetylcholine receptors.[2]

Structure

The anabaseine molecule consists of a non-aromatic tetrahydropyridine ring connected to the 3rd carbon of a 3-pyridyl ring. It can exist in three forms at physiological pH: a ketone, imine, or iminium structure.[2] Due to conjugation between the imine and 3-pyridyl ring, anabaseine exists as a nearly coplanar molecule.

Synthesis

Spath and Mamoli first synthesized anabaseine in 1936.[4] The researchers reacted benzoic anhydride with δ-valerolactam to yield N-benzoylpiperidone. Then, N-benzoylpiperidone is reacted with nicotinic acid ethyl ester to produce α-nicotinoyl-N-benzoyl-2-piperidone. This product then is decarboxylated, undergoes a ring closure, and amide hydrolysis to form anabaseine.

Additional synthetic strategies have since been developed by Bloom,[5] Zoltewicz,[6] Smith,[7] and Villemin.[8]

Derivatives

Due to anabaseine’s fairly non-specific binding to nicotinic acetylcholine receptors, the molecule was largely discarded as a useful tool in research or medicine. However, anabaseine derivatives have been identified with a more selective α7 binding profile. One such derivative (GTS-21, 3-(2,4-dimethoxybenzylidene)-anabaseine) has been studied as a drug candidate for cognitive and memory deficits, particularly associated with schizophrenia; it has been studied in phase II clinical trials without progression to phase III.[9]

References

  1. ↑ Wheeler, JW; Olubajo, O; Storm, CB; Duffield, RM (6 March 1981). "Anabaseine: venom alkaloid of aphaenogaster ants.". Science 211 (4486): 1051–2. doi:10.1126/science.211.4486.1051. PMID 17744933.
  2. 1 2 3 4 5 Kem, William; Soti, Ferenc; Wildeboer, Kristin; LeFrancois, Susan; MacDougall, Kelly; Wei, Dong-Qing; Chou, Kuo-Chen; Arias, Hugo R. (2006-04-06). "The Nemertine Toxin Anabaseine and Its Derivative DMXBA (GTS-21): Chemical and Pharmacological Properties". Marine Drugs 4 (3): 255–273. doi:10.3390/md403255. Retrieved 2015-04-20.
  3. ↑ Kem, WR; Mahnir, VM; Papke, RL; Lingle, CJ (December 1997). "Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.". The Journal of Pharmacology and Experimental Therapeutics 283 (3): 979–92. PMID 9399967.
  4. ↑ Padilla, Edited by Dean F. Martin [and] George M. (1973). Marine pharmacognosy; action of marine biotoxins at the cellular level. (First ed.). New York: Academic Press. pp. 54–55. ISBN 978-0124745506.
  5. ↑ Bloom, Linda. "Influence of solvent on the ring-chain hydrolysis equilibrium of anabaseine and synthesis of anabaseine and nicotine analogues.". University of Florida. Retrieved 5 May 2015.
  6. ↑ Zoltewicz, John A.; Cruskie, Michael P. (August 1995). "A Superior Synthesis of Cholinergic Anabaseine". Organic Preparations and Procedures International 27 (4): 510–513. doi:10.1080/00304949509458490.
  7. ↑ Smith, Aaron. "Synthesis and Radiolabeling of Potassium Trifluoroborate Benzilidene Anabaseine Derivatives". University of Tennessee - Knoxville.
  8. ↑ Villemin, Didier; Hachemi, Messaoud (2001). "Cesium Fluoride on Calcium Oxide as a Strongly Basic Catalyst. Synthesis of Flavones and Tobacco Alkaloids". Reaction Kinetics and Catalysis Letters 72 (1): 3–10. doi:10.1023/A:1010597826749.
  9. ↑ Celanire, Sylvain; Poli, Sonia (2014-10-13). Small Molecule Therapeutics for Schizophrenia. Springer. p. 248. ISBN 9783319115023. Retrieved 2015-04-20.
This article is issued from Wikipedia - version of the Wednesday, January 27, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.